PL431069A1 - Zestaw do wykrywania wirusa grypy zawierający bufor, linker oraz sekwencję aminokwasową oraz sposób detekcji - Google Patents

Zestaw do wykrywania wirusa grypy zawierający bufor, linker oraz sekwencję aminokwasową oraz sposób detekcji

Info

Publication number
PL431069A1
PL431069A1 PL431069A PL43106919A PL431069A1 PL 431069 A1 PL431069 A1 PL 431069A1 PL 431069 A PL431069 A PL 431069A PL 43106919 A PL43106919 A PL 43106919A PL 431069 A1 PL431069 A1 PL 431069A1
Authority
PL
Poland
Prior art keywords
influenza virus
buffer
virus detection
amino acid
acid sequence
Prior art date
Application number
PL431069A
Other languages
English (en)
Inventor
Krzysztof Urbański
Jakub MNICH
Dawid NIDZWORSKI
Maciej SASOWSKI
Elżbieta CZACZYK
Marcin HAŁUPKA
Paweł POLAŃSKI
Jakub ANIULIS
Grzegorz HENIG
Izabela Załuska
Joanna KRECZKO
Piotr BARSKI
Original Assignee
Sensdx Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sensdx Spółka Akcyjna filed Critical Sensdx Spółka Akcyjna
Priority to PL431069A priority Critical patent/PL431069A1/pl
Priority to EP20863767.8A priority patent/EP4028765A4/en
Priority to PCT/PL2020/050063 priority patent/WO2021049961A1/en
Publication of PL431069A1 publication Critical patent/PL431069A1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438—Electrodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Zestaw do wykrywania wirusa grypy zawierający urządzenie pomiarowe oraz bufor charakteryzujący się tym, że bufor zawiera 100 mM TRIS - HCl, 6.2 mM potasu heksacyjanożelazian (II), 6.2 mM. Potasu heksacyjanożelazin (III), 0.1% TWEEN 20 o pH w zakresie od 7,00 do 8.00 a urządzenie pomiarowe zawiera w obudowie mikrokontroler, który poprzez frontend analogowy jest połączony z biosensorem do którego za pomocą linkera o wzorze sumarycznym HSCH2(CH2)8CH2-CO- połączona jest cząsteczka do detekcji wirusa grypy o sekwencji aminokwasowej: Met Leu Pro Phe Arg Thr Asp oraz poprzez interfejs komunikacyjny z hostem PC i bezpośrednio ze wskaźnikami, korzystnie ledowymi. Przedmiotem niniejszego zgłoszenia jest także bufor do detekcji wirusa grypy oraz cząsteczka do detekcji wirusa grypy o sekwencji aminokwasowej: Met Leu Pro Phe Arg Thr Asp. Zgłoszenie obejmuje także linker łączony z wyżej zdefiniowaną cząsteczką oraz sposób detekcji wirusa grypy w próbkach biologicznych albo przemysłowych.
PL431069A 2019-09-09 2019-09-09 Zestaw do wykrywania wirusa grypy zawierający bufor, linker oraz sekwencję aminokwasową oraz sposób detekcji PL431069A1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL431069A PL431069A1 (pl) 2019-09-09 2019-09-09 Zestaw do wykrywania wirusa grypy zawierający bufor, linker oraz sekwencję aminokwasową oraz sposób detekcji
EP20863767.8A EP4028765A4 (en) 2019-09-09 2020-09-08 INFLUENZA VIRUS DETECTION KIT COMPRISING A BUFFER, A LINKER AND AN AMINO ACID SEQUENCE AND A DETECTION METHOD
PCT/PL2020/050063 WO2021049961A1 (en) 2019-09-09 2020-09-08 An influenza virus detection kit comprising a buffer, a linker and an amino acid sequence and a detection method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL431069A PL431069A1 (pl) 2019-09-09 2019-09-09 Zestaw do wykrywania wirusa grypy zawierający bufor, linker oraz sekwencję aminokwasową oraz sposób detekcji

Publications (1)

Publication Number Publication Date
PL431069A1 true PL431069A1 (pl) 2021-03-22

Family

ID=74866346

Family Applications (1)

Application Number Title Priority Date Filing Date
PL431069A PL431069A1 (pl) 2019-09-09 2019-09-09 Zestaw do wykrywania wirusa grypy zawierający bufor, linker oraz sekwencję aminokwasową oraz sposób detekcji

Country Status (3)

Country Link
EP (1) EP4028765A4 (pl)
PL (1) PL431069A1 (pl)
WO (1) WO2021049961A1 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013034688A1 (en) * 2011-09-09 2013-03-14 Danmarks Tekniske Universitet Biosensor for point-of-care diagnostic and on-site measurements
PL223208B1 (pl) * 2012-07-16 2016-10-31 Univ Gdański Sposób przygotowania immunoczujnika oraz jego zastosowanie do wykrywania wirusa grypy
EP3356823B1 (en) * 2015-09-28 2020-04-22 Sensdx Sp. z o.o. A modified bdd substrate and its use as an impedance sensor for detection of biological molecules and a system and method for monitoring pathogens
KR101892040B1 (ko) * 2017-01-25 2018-08-27 원광대학교산학협력단 인플루엔자 a형 바이러스의 h5 아형에 특이적으로 결합하는 펩티드 및 이의 용도

Also Published As

Publication number Publication date
WO2021049961A1 (en) 2021-03-18
EP4028765A4 (en) 2023-12-13
EP4028765A1 (en) 2022-07-20

Similar Documents

Publication Publication Date Title
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
WO2006128138A3 (en) Biodetection by nucleic acid-templated chemistry
ATE554389T1 (de) Apex als marker für lungenkrebs
JP2015531765A5 (pl)
DE602004021281D1 (de) Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren
MX2022002600A (es) Detección de alfa-sinucleína mediante el uso de perlas.
ES2774132T3 (es) Método para identificar neutralizadores de malos olores
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
PL431069A1 (pl) Zestaw do wykrywania wirusa grypy zawierający bufor, linker oraz sekwencję aminokwasową oraz sposób detekcji
DK1485481T3 (da) Fflourescerende protein fra Aequorea Coerulescens og anvendelser deraf
K Flores et al. Biophysical characterisation and quantification of nucleic acid-protein interactions: EMSA, MST and SPR
CN109180561B (zh) 查尔酮类荧光探针在检测水溶液中苯硫酚类化合物的应用
JP2019537434A (ja) ルシフェリン分解産物による阻害に対して改善された耐性を持つ熱安定性ルシフェラーゼ
CN109212207A (zh) 用于检测口腔中流感病毒血凝素蛋白的荧光试剂及其制备方法和检测方法
Deng et al. Trace determination of short-chain aliphatic amines in biological samples by micellar electrokinetic capillary chromatography with laser-induced fluorescence detection
ATE359516T1 (de) Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs
US20180051314A1 (en) Compounds, substrates and methods related to histone deacetylases
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
CN104844666B (zh) 含唾液酸糖基萘酰亚胺类化合物及其在流感病毒检测中的应用
DK1781807T3 (da) Fluorescensbaseret kinetisk måling af transglutaminaseaktivitet
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
JP2006503582A (ja) Ｉｐ３タンパク質結合測定法
KR101455176B1 (ko) ｙｑｊＬ유전자 발현 산물의 형광 영상화를 통한 바실러스 서브틸리스 검출 방법
DE602004017017D1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome